Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Single Arm Study to Evaluate the Impact on the Implementation of Standardized Hyperkalemia Management in Chronic Kidney Disease Patients

NCT06884267 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06884267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06884267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Single Arm Study to Evaluate the Impact on the Implementation of Standardized Hyperkalemia Management in Chronic Kidney Disease Patients
Lead sponsor
AstraZeneca
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 25, 2025
Completion date
December 11, 2027
Enrollment
1,000 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalemia